Activated Cyclin-Dependent Kinase 5 Promotes Microglial Phagocytosis of Fibrillar β-Amyloid by Up-regulating Lipoprotein Lipase Expression

Yuanhui Ma, Jintao Bao, Xuyang Zhao, Hongyan Shen, Junniao Lv, Shuaipeng Ma, Xuefei Zhang, Zeyang Li, Shuxin Wang, Qingsong Wang,

Molecular & Cellular Proteomics · 2013 · 60 citations · 49 references

DOIFull text

Open access

Concepts

Abstract

Amyloid plaques are crucial for the pathogenesis of Alzheimer disease (AD). Phagocytosis of fibrillar β-amyloid (Aβ) by activated microglia is essential for Aβ clearance in Alzheimer disease. However, the mechanism underlying Aβ clearance in the microglia remains unclear. In this study, we performed stable isotope labeling of amino acids in cultured cells for quantitative proteomics analysis to determine the changes in protein expression in BV2 microglia treated with or without Aβ. Among 2742 proteins identified, six were significantly up-regulated and seven were down-regulated by Aβ treatment. Bioinformatic analysis revealed strong over-representation of membrane proteins, including lipoprotein lipase (LPL), among proteins regulated by the Aβ stimulus. We verified that LPL expression increased at both mRNA and protein levels in response to Aβ treatment in BV2 microglia and primary microglial cells. Silencing of LPL reduced microglial phagocytosis of Aβ, but did not affect degradation of internalized Aβ. Importantly, we found that enhanced cyclin-dependent kinase 5 (CDK5) activity by increasing p35-to-p25 conversion contributed to LPL up-regulation and promoted Aβ phagocytosis in microglia, whereas inhibition of CDK5 reduced LPL expression and Aβ internalization. Furthermore, Aβ plaques was increased with reducing p25 and LPL level in APP/PS1 mouse brains, suggesting that CDK5/p25 signaling plays a crucial role in microglial phagocytosis of Aβ. In summary, our findings reveal a potential role of the CDK5/p25-LPL signaling pathway in Aβ phagocytosis by microglia and provide a new insight into the molecular pathogenesis of Alzheimer disease. Amyloid plaques are crucial for the pathogenesis of Alzheimer disease (AD). Phagocytosis of fibrillar β-amyloid (Aβ) by activated microglia is essential for Aβ clearance in Alzheimer disease. However, the mechanism underlying Aβ clearance in the microglia remains unclear. In this study, we performed stable isotope labeling of amino acids in cultured cells for quantitative proteomics analysis to determine the changes in protein expression in BV2 microglia treated with or without Aβ. Among 2742 proteins identified, six were significantly up-regulated and seven were down-regulated by Aβ treatment. Bioinformatic analysis revealed strong over-representation of membrane proteins, including lipoprotein lipase (LPL), among proteins regulated by the Aβ stimulus. We verified that LPL expression increased at both mRNA and protein levels in response to Aβ treatment in BV2 microglia and primary microglial cells. Silencing of LPL reduced microglial phagocytosis of Aβ, but did not affect degradation of internalized Aβ. Importantly, we found that enhanced cyclin-dependent kinase 5 (CDK5) activity by increasing p35-to-p25 conversion contributed to LPL up-regulation and promoted Aβ phagocytosis in microglia, whereas inhibition of CDK5 reduced LPL expression and Aβ internalization. Furthermore, Aβ plaques was increased with reducing p25 and LPL level in APP/PS1 mouse brains, suggesting that CDK5/p25 signaling plays a crucial role in microglial phagocytosis of Aβ. In summary, our findings reveal a potential role of the CDK5/p25-LPL signaling pathway in Aβ phagocytosis by microglia and provide a new insight into the molecular pathogenesis of Alzheimer disease. Alzheimer disease (AD) 1The abbreviations used are:ADAlzheimer's diseaseApoEApoliprotein EAPPβ-amyloid precursor proteinCNBPCellular nucleic acid-binding proteinEMelectron microscopyfAβfibrillar β-amyloidFASPfilter aided sample preparationGAGglycosaminoglycanGFAPglial fibrillary acidic proteinLPLlipoprotein lipaseNFTneurofibrillary tanglePBSphosphate-buffered salineSILACstable isotope labeling of amino acid in cell culturesSNPsingle nucleotide polymorphismSR-Ascavenger receptor ASR-BIscavenger receptor class B type ITLR2Toll-like receptor 2TLR4Toll-like receptor 4. 1The abbreviations used are:ADAlzheimer's diseaseApoEApoliprotein EAPPβ-amyloid precursor proteinCNBPCellular nucleic acid-binding proteinEMelectron microscopyfAβfibrillar β-amyloidFASPfilter aided sample preparationGAGglycosaminoglycanGFAPglial fibrillary acidic proteinLPLlipoprotein lipaseNFTneurofibrillary tanglePBSphosphate-buffered salineSILACstable isotope labeling of amino acid in cell culturesSNPsingle nucleotide polymorphismSR-Ascavenger receptor ASR-BIscavenger receptor class B type ITLR2Toll-like receptor 2TLR4Toll-like receptor 4. is one of the most common neurodegenerative disorders, which is characterized by pathological hallmarks such as neuronal and synaptic loss, neurofibrillary tangles (NFTs), and senile plaques. The intracellular NFTs are mainly composed of hyper-phosphorylated microtubule-associated protein tau, whereas toxic fibrillar β-amyloid (fAβ) as the main component of senile plaques is generated by sequential proteolytic cleavage of trans-membrane β-amyloid precursor protein (APP) by β- and γ-secretases. fAβ can induce oxidative stress-mediated neuronal cell death and cause cognitive impairment in mouse brains (1Sultana R. Butterfield D.A. Role of oxidative stress in the progression of Alzheimer's disease.J. Alzheimers Dis. 2010; 19: 341-353Crossref PubMed Scopus (268) Google Scholar). Many reports suggest that fAβ induces dysregulation of two pivotal kinases CDK5 (2Cruz J.C. Kim D. Moy L.Y. Dobbin M.M. Sun X. Bronson R.T. Tsai L.H. p25/cyclin-dependent kinase 5 induces production and intraneuronal accumulation of amyloid beta in vivo.J. Neurosci. 2006; 26: 10536-10541Crossref PubMed Scopus (174) Google Scholar, 3Patrick G.N. Zukerberg L. Nikolic M. de la Monte S. Dikkes P. Tsai L.H. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.Nature. 1999; 402: 615-622Crossref PubMed Scopus (1236) Google Scholar) and GSK-3 (4Avila J. Wandosell F. Hernández F. Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors.Expert Rev. Neurother. 2010; 10: 703-710Crossref PubMed Scopus (99) Google Scholar), which are crucial regulators of hyperphosphorylated tau and increased production of Aβ from APP, and thereby triggers the cascade of signal transduction events underlying neuronal cell death in AD pathogenesis. Alzheimer's disease Apoliprotein E β-amyloid precursor protein Cellular nucleic acid-binding protein electron microscopy fibrillar β-amyloid filter aided sample preparation glycosaminoglycan glial fibrillary acidic protein lipoprotein lipase neurofibrillary tangle phosphate-buffered saline stable isotope labeling of amino acid in cell cultures single nucleotide polymorphism scavenger receptor A scavenger receptor class B type I Toll-like receptor 2 Toll-like receptor 4. Alzheimer's disease Apoliprotein E β-amyloid precursor protein Cellular nucleic acid-binding protein electron microscopy fibrillar β-amyloid filter aided sample preparation glycosaminoglycan glial fibrillary acidic protein lipoprotein lipase neurofibrillary tangle phosphate-buffered saline stable isotope labeling of amino acid in cell cultures single nucleotide polymorphism scavenger receptor A scavenger receptor class B type I Toll-like receptor 2 Toll-like receptor 4. As the resident immune cells in the brain, microglia can be activated in response to fAβ and often accumulate around the amyloid deposits in the brains of AD patients. Activated microglia trigger the production of inflammatory factors, reactive oxygen species, and chemokines, which may cause neuronal cell death (5Amor S. Puentes F. Baker D. van der Valk P. Inflammation in neurodegenerative diseases.Immunology. 2010; 129: 154-169Crossref PubMed Scopus (951) Google Scholar). Furthermore, increasing evidence supports that activated microglia exert a vital beneficial role in the clearance of Aβ by phagocytosis. Many receptors, including scavenger receptor A (SR-A) (6Paresce D.M. Ghosh R.N. Maxfield F.R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor.Neuron. 1996; 17: 553-565Abstract Full Text Full Text PDF PubMed Scopus (580) Google Scholar), scavenger receptor class B type I (SR-BI) (7Husemann J. Loike J.D. Kodama T. Silverstein S.C. Scavenger receptor class B type I (SR-BI) mediates adhesion of neonatal murine microglia to fibrillar beta-amyloid.J. Neuroimmunol. 2001; 114: 142-150Abstract Full Text Full Text PDF PubMed Scopus (106) Google Scholar), lipopolysaccharide receptor (CD14) (8Liu Y. Walter S. Stagi M. Cherny D. Letiembre M. Schulz-Schaeffer W. Heine H. Penke H. receptor a receptor for phagocytosis of Alzheimer's amyloid PubMed Scopus Google Scholar), Alzheimer's Microglial of Amyloid Full Text Full Text PDF PubMed Scopus Google Scholar), scavenger receptor T. promotes accumulation of by clearance of PubMed Scopus Google Scholar), Y. signaling in a and 2010; PubMed Scopus Google Scholar), J. Microglial phagocytosis of fibrillar a Neurosci. PubMed Scopus Google Scholar), receptor 2 P. J. J. W. S. of Toll-like receptor 2 microglia promotes cell of Alzheimer amyloid beta 2006; Full Text Full Text PDF PubMed Scopus Google Scholar), and receptor M. J. J. Kim R. microglial deposits and cognitive in a mouse of Alzheimer's disease.J. PubMed Scopus Google Scholar), in microglial phagocytosis of fAβ via or to Aβ. Microglial phagocytosis of fAβ is regulated by J. Microglial phagocytosis by fibrillar and are regulated by Neurosci. PubMed Scopus Google Scholar) and receptor R. J. in microglia amyloid Neurosci. 2010; PubMed Scopus Google Scholar). that the component which is for cleavage and Aβ production in is for microglial fAβ a role for in neuronal cell death and microglial phagocytosis D. D. R. R. D. component is for microglia PubMed Scopus Google Scholar). In evidence a role of and in microglial fAβ phagocytosis and that E fAβ and a role of in fAβ degradation W. J.D. E promotes and degradation by microglial Full Text Full Text PDF PubMed Scopus Google Scholar). fAβ is the pathway D. Maxfield F.R. of Alzheimer's amyloid by microglia of to PubMed Google Scholar, D. P. Maxfield F.R. of microglia and to degradation of Alzheimer amyloid PubMed Scopus Google Scholar). However, the mechanism underlying microglial of fAβ remains unclear. isotope labeling of amino acids in cell is and quantitative proteomics for changes in protein expression or at a M. A for stable isotope labeling by amino acids in cell 2006; PubMed Scopus Google Scholar, H. M. isotope labeling by amino acids in cell as a and to expression Full Text Full Text PDF PubMed Scopus Google Scholar). we used the quantitative proteomics to changes in the protein levels in BV2 microglia treated with We found that proteins were up-regulated and were down-regulated significantly by Aβ treatment. analysis revealed that most of or down-regulated proteins, including lipoprotein lipase (LPL), were mainly in the cell We verified that LPL was up-regulated at both and protein levels in BV2 and primary microglia in response to thereby role in the microglial phagocytosis of Aβ. Importantly, we that which is a kinase in the pathogenesis of regulated the expression of LPL and a role in Aβ phagocytosis of we found that in the p35-to-p25 conversion contributed to the enhanced CDK5 activity Aβ and a vital role in of LPL expression and microglial Aβ phagocytosis. suggest a role of the CDK5/p25-LPL signaling pathway in Aβ phagocytosis of microglia and provide to the molecular mechanism underlying microglial fAβ phagocytosis. was in and at for The of the aggregates was by electron of was a for the the were with acid and by electron microscopy at BV2 microglia were from the of and in with and BV2 cells were cultured at with and BV2 cells were cultured in and with and and or and cells were at a of 5 cells were with for cells were treated with 2 fAβ for and cells were treated with the of as the microglia were from brains of to a Amyloid signaling and production in Neurosci. 17: PubMed Google Scholar, J. J. of murine microglia by PubMed Scopus Google Scholar). were and the and were from the which were and with and I for at and was used to the were and The was with and the cells were cultured for at and microglia were by the for 2 at at to were and at the for in The cells were cultured and as to primary microglia the the was to and the cells were cultured The microglia were as by cells that were for and glial fibrillary acidic protein and BV2 cells were with and in 2 and with at and the protein of the was with a were and protein of protein were The protein were with to the filter aided sample preparation M. sample preparation for PubMed Scopus Google Scholar). The were in a and and into a the were by a to the by the were with acid and with of 2006; PubMed Scopus Google Scholar). The were in and by a which was with a The was with of in acid at a of for The was to to a The was to in were in the with a of accumulation of The most from the in the were by and in the the accumulation of were for the and for the was and as as were The was to a of with a of and a of The were were with J. M. and protein 26: PubMed Scopus Google Scholar, J. M. M. M. A to the for quantitative PubMed Scopus Google Scholar) that and to protein and and of the were The were the mouse protein protein with and with of were as was to two as and were as was to for precursor and to for The was to at and protein and the was to seven amino one or protein was for protein protein with at two were for The was used to determine and were among proteins R. P. M. X. F. analysis and of PubMed Scopus Google Scholar, D. R. a and analysis for PubMed Scopus Google Scholar). and pathway analysis were performed by the of the proteins in a of the and in the was the with quantitative was used to determine the expression of LPL in BV2 cells or mouse primary BV2 cells or primary microglia were in and in the or of 2 for in The cells were with and in to the to the of was to a was and by a The were to the in of mRNA expression was by the as by the The cells were in of and a The protein was by a were by and a with in with the were at with primary and a The primary were used in this mouse lipase mouse and were by The protein was to the expression level of were of BV2 cells in for were with CDK5 p35 or with cells were treated with at for and Aβ in the was as BV2 cells or primary microglia were treated with or for the cells were treated with for Aβ levels in the were as The with p25 was into BV2 cells as the of the cells were treated with at for The levels of and Aβ in the were as BV2 cells were treated with 2 in 5 and a at for and at for The protein were with primary at for 2 A were by for 2 at The were with and kinase and A kinase of and was to the protein by at for The kinase was by of were for 5 and by The was and by were in the and at for were by and with for and Aβ. BV2 cells were with or as microglia were with at for the cells were with and in for and Aβ levels in the cell were by as were the and as the of at of were by or and was used to two of The level was at The of aggregates was characterized by electron analysis that of and were the main in the inflammatory of microglia T. The is in the immune response to PubMed Scopus Google Scholar, J. J. J. J. S. of by microglia treatment revealed by PubMed Scopus Google Scholar). of BV2 cells by 2 fAβ was revealed by of and As in was as as fAβ treatment and levels whereas at treatment. that fAβ enhanced the microglial production of inflammatory and microglial determine activated microglia can BV2 cells were with 2 A of Aβ was in BV2 cells of fAβ that BV2 cells internalized Aβ We increased levels of Aβ of treatment with 2 fAβ insight into the degradation pathway of internalized we the of internalized and BV2 cells were with and for We found that were with suggesting that the internalized was into that BV2 cells be activated and we the proteins that be in microglial phagocytosis of fAβ by and analysis BV2 microglia were with and or and cells were treated with 2 fAβ for protein from and cells were the were by and to were as and A of were for 2742 proteins were at a of and proteins without of which proteins were the for the among the we a among of with a of at or were as we proteins that were in at two protein were found to be among which six were up-regulated and seven were down-regulated by Aβ treatment I protein of Aβ treated BV2 of by that by which with to membrane in 2 beta amino acid synthase of by that by which with to membrane in a new insight into the of and down-regulated proteins, we performed analysis of the and of regulated proteins, as by we found that proteins, including and were in the cell membrane by component analysis plays a role in Aβ clearance to Aβ and degradation W. J.D. E promotes and degradation by microglial Full Text Full Text PDF PubMed Scopus Google Scholar). the of our the pathway we found that and down-regulated proteins were in the signaling and signaling and the pathway are in Aβ clearance by activated microglia of PubMed Scopus Google Scholar). of the expression levels of the proteins by fAβ treatment that proteins may be in fAβ microglial or phagocytosis. LPL the of and mediates of by as a and or lipoprotein in M. P. H. van lipoprotein receptor and that are to via lipoprotein Full Text PDF PubMed Google Scholar, by which lipoprotein lipase of and for lipoprotein and Full Text PDF PubMed Google Scholar). to be up-regulated in AD we LPL for LPL expression was in BV2 and primary microglia by quantitative and As in LPL increased at mRNA and protein levels by fAβ treatment. were with the LPL is in microglial phagocytosis of of LPL expression was performed by of for of both the mRNA and protein levels of LPL to and of that in the the cells were treated with fAβ at for that of fAβ by microglia was significantly by LPL We LPL in degradation of the internalized Aβ. of LPL for BV2 cells were with fAβ at for in and cultured at for or The Aβ levels in cell were by Aβ was for Aβ in the cell whereas Aβ was in LPL cells. Aβ in both that the internalized Aβ in and LPL BV2 cells in a that of LPL the degradation of internalized Aβ As signaling dysregulation of CDK5 is in tau and Aβ and for neuronal cell death M. J. Tsai L.H. induces cleavage of p35 to p25 by PubMed Scopus Google Scholar). is in activated microglia and Aβ phagocytosis. In this study, to the role of CDK5 in LPL expression and microglial phagocytosis of we treated BV2 cells with the CDK5 and of LPL which that CDK5 LPL LPL is in fAβ phagocytosis by microglia, we the of the of fAβ in BV2 cells. As in of in microglia to of that in the In primary microglia, we that treatment to in the of Aβ to we found that CDK5 LPL expression and significantly microglial phagocytosis of Aβ that CDK5 a role in microglial phagocytosis of Aβ, and may Aβ as for p35 is in CDK5 cleavage of p35 to p25 by to enhanced CDK5 of tau proteins, and neuronal cell death D. in Cdk5 and PubMed Scopus Google Scholar, L.H. T. p35 is a of cyclin-dependent kinase PubMed Scopus Google Scholar). determine the CDK5 p25 is in Aβ we treated primary microglia with 2 fAβ for and found that the conversion of p35 to p25 increased significantly In CDK5 was to activity as a in BV2 cells. As in CDK5 kinase activity was significantly fAβ treatment. p25 is in of LPL expression and Aβ we for p35 and into BV2 cells for BV2 cells were treated with fAβ at for As in p35 LPL expression and microglial phagocytosis of Aβ p25 of LPL and enhanced microglial phagocytosis of Aβ findings that the in p35 to p25 cleavage increased CDK5 activity and enhanced Aβ by LPL suggesting that CDK5/p25 signaling is which LPL expression and promotes microglial phagocytosis of Activated microglia to a beneficial role in Aβ We that level of p25 may CDK5 activity and LPL expression to Aβ phagocytosis. we CDK5/p25 signaling is activated in APP/PS1 mouse We p35 to p25 LPL and Aβ at of APP/PS1 and We a in p25 and LPL expression in the brains of and 2 APP/PS1 with that in that Aβ However, of p25 cleavage and LPL levels in the brains was of Aβ in the brains of 5 and of APP/PS1 suggest that CDK5/p25-LPL signaling is activated in the microglia, which a beneficial microglial Aβ clearance in The of Aβ is a in AD As the main component of senile Aβ and Aβ are crucial in AD pathogenesis. In the brains of with activated microglia to be for of toxic Aβ clearance S. and in Alzheimer's 2010; PubMed Scopus Google Scholar, S. of immune in the Rev. PubMed Scopus Google Scholar). The mechanism underlying the microglial of Aβ remains unclear. In the study, we the changes of proteins in BV2 microglia treated with fAβ the and six up-regulated and seven down-regulated proteins in BV2 of proteins are with we found that of regulated proteins were cell membrane Among LPL expression increased at mRNA and protein expression levels in BV2 and primary microglia with fAβ stimulus. We found that of LPL reduced microglial Aβ but the degradation of internalized Aβ. Furthermore, we that the CDK5/p25 was activated and that was in Aβ at in by LPL suggesting that CDK5/p25 signaling plays role in microglial phagocytosis of Aβ. As the immune cell type in brains, activated microglia are a of toxic factors, such as and which are to and a pathological PubMed Scopus Google Scholar). inflammatory signaling is essential for the of toxic and from activated In our study, and were in signaling Y. J. of as a in the of by PubMed Scopus Google Scholar, H. H. H. D. kinase is for of 2010; PubMed Scopus Google Scholar). activated microglia and proteolytic to and toxic Aβ (6Paresce D.M. Ghosh R.N. Maxfield F.R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor.Neuron. 1996; 17: 553-565Abstract Full Text Full Text PDF PubMed Scopus (580) Google Scholar). The cell are for and of Aβ. membrane proteins are in Aβ including (6Paresce D.M. Ghosh R.N. Maxfield F.R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor.Neuron. 1996; 17: 553-565Abstract Full Text Full Text PDF PubMed Scopus (580) Google Scholar), (7Husemann J. Loike J.D. Kodama T. Silverstein S.C. Scavenger receptor class B type I (SR-BI) mediates adhesion of neonatal murine microglia to fibrillar beta-amyloid.J. Neuroimmunol. 2001; 114: 142-150Abstract Full Text Full Text PDF PubMed Scopus (106) Google Scholar), (8Liu Y. Walter S. Stagi M. Cherny D. Letiembre M. Schulz-Schaeffer W. Heine H. Penke H. receptor a receptor for phagocytosis of Alzheimer's amyloid PubMed Scopus Google Scholar), Alzheimer's Microglial of Amyloid Full Text Full Text PDF PubMed Scopus Google Scholar), T. promotes accumulation of by clearance of PubMed Scopus Google Scholar), Y. signaling in a and 2010; PubMed Scopus Google Scholar), J. Microglial phagocytosis of fibrillar a Neurosci. PubMed Scopus Google Scholar), P. J. J. W. S. of Toll-like receptor 2 microglia promotes cell of Alzheimer amyloid beta 2006; Full Text Full Text PDF PubMed Scopus Google Scholar), and M. J. J. Kim R. microglial deposits and cognitive in a mouse of Alzheimer's disease.J. PubMed Scopus Google Scholar). In our study, of the proteins regulated by Aβ treatment were mainly as cell membrane proteins including and and LPL were up-regulated in microglia, suggesting potential role in microglial phagocytosis of Aβ. In to affect the of Aβ by Aβ J. D.M. The role of E in Alzheimer's Full Text Full Text PDF PubMed Scopus Google Scholar) and Aβ degradation S. P. J.C. J.D. D. D.M. P. promotes the proteolytic degradation of Full Text Full Text PDF PubMed Scopus Google Scholar, M. S. X. M. D. J. R. F. S. E promotes and degradation of 10: PubMed Scopus Google Scholar). that LPL promotes of Aβ in by a with Aβ without the of suggesting a role of LPL in the microglial of Aβ T. M. lipase is a amyloid beta protein that promotes of in Full Text Full Text PDF PubMed Scopus Google Scholar). LPL the of and mediates the of M. P. H. van lipoprotein receptor and that are to via lipoprotein Full Text PDF PubMed Google Scholar, by which lipoprotein lipase of and for lipoprotein and Full Text PDF PubMed Google Scholar). that a role in AD pathogenesis. LPL to be in amyloid plaques in the of AD brains L. L. lipase and Alzheimer's J. 1999; PubMed Scopus Google Scholar, and of lipoprotein lipase in the Full Text PDF PubMed Google Scholar). A single nucleotide polymorphism in the LPL is with AD L. D. J. A polymorphism in lipoprotein lipase the of Alzheimer's disease J. Neurosci. 2006; PubMed Scopus Google Scholar). In the of AD was found to be reduced among and this is by of the amyloid precursor protein A and 2001; PubMed Scopus Google Scholar). that to LPL activity J. J.C. J. levels of and lipoprotein 1999; PubMed Scopus Google Scholar), LPL may a for the treatment and of that LPL reduced the of Aβ, but the degradation of Aβ in The up-regulation of LPL in response to Aβ be to microglial Aβ and we for the the role of LPL as a of microglial phagocytosis and clearance of Aβ in the We a role for the CDK5/p25 in Aβ phagocytosis and clearance by CDK5 is a protein kinase in AD and activity is regulated by cleavage of the p35 to CDK5 plays a role in neuronal cell and in the Tsai L.H. is a a at Rev. PubMed Scopus Google Scholar, P. L. S. M. kinase 5 is of neuronal PubMed Scopus Google Scholar). In AD brains, increased cleavage of p35 to p25 of Aβ in of the CDK5/p25 and CDK5 G.N. Zukerberg L. Nikolic M. de la Monte S. Dikkes P. Tsai L.H. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.Nature. 1999; 402: 615-622Crossref PubMed Scopus (1236) Google Scholar), which the of such as hyperphosphorylated tau proteins M. J. Tsai L.H. induces cleavage of p35 to p25 by PubMed Scopus Google Scholar). expression of the CDK5/p25 in cultured primary induces P. L. S. M. kinase 5 is of neuronal PubMed Scopus Google Scholar), and G.N. Zukerberg L. Nikolic M. de la Monte S. Dikkes P. Tsai L.H. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.Nature. 1999; 402: 615-622Crossref PubMed Scopus Google Scholar). In CDK5/p25 Aβ production by and the that the disease in AD the that p25 by the triggers and D. D. P. H. F. and in A for and J. Full Text Full Text PDF PubMed Scopus Google Scholar). CDK5 a role in phagocytosis of Aβ in microglia is unclear. In this study, we found that the increased in the p35-to-p25 conversion in the microglia contributed to enhanced CDK5 which was by in LPL expression and of microglial Aβ phagocytosis. can be activated amyloid in the of AD J. M. in the of microglia and microglial in a of Alzheimer's Dis. 2010; PubMed Scopus Google Scholar) and a role in reducing Aβ accumulation by Aβ and degradation F. M. Microglial response to amyloid plaques in J. Google Scholar, D.M. J. levels of amyloid beta-protein by Full Text Full Text PDF PubMed Scopus Google Scholar). we found that the CDK5/p25 was for microglial phagocytosis of Aβ and by of LPL of in microglial Aβ may provide new for AD treatment. In summary, we used quantitative proteomics analysis to reveal the changes in the protein levels in BV2 microglia by Among the 2742 proteins, six were up-regulated and seven were down-regulated significantly by Aβ. of and down-regulated proteins were cell membrane proteins such as and We verified that LPL is a in of Aβ, but not a in Aβ degradation by Furthermore, we found that the CDK5/p25 is activated and to LPL which in in microglial Aβ phagocytosis are to CDK5/p25 signaling LPL expression and microglial phagocytosis at the the role of CDK5/p25 signaling in neuronal cell our may in CDK5 for the treatment of findings provide new into the molecular pathogenesis of AD and a potential for AD with

References

49